Neoantigens Market Segments, Top Vendors, Opportunities and Forecast by 2028Posted by Avi on October 20th, 2022 The Neoantigens Market are recently developed antigens that have not been detected by the immune system historically. Alterations in tumor proteins may result in the development of neoantigens caused by mutations or viral proteins. Neoantigens are used in selective treatments for cancerous cells. The market is expected to grow due to the key factors such as developments in neoantigen vaccines against cancer and increasing prevalence of cancer. However, the possible side effects associated with neoantigen vaccines are expected to restraint the growth of the market during the forecast years. Get Sample Copy @ https://www.theinsightpartners.com/sample/TIPRE00021781/ Top Companies - The most notable market participants are Achilles Therapeutics plc, Advaxis, Inc., Frame Cancer Therapeutics, Genocea, Gradalis, Inc., Gritstone Oncology, Immunicum AB, Medigene AG, Ziopharm Oncology, Inc., and Moderna, Inc. among others, occupying a considerable share of the market owing to their offerings to the market. Many biotechnology companies are involved in the development of neoantigens, and most of them are in the clinical and pre-clinical phases of development. As per the data obtained from ClinicalTrials.gov, many clinical studies have been completed and moved on to the next stage of clinical trials in the US and other countries. For instance, Phase 1 study of ADXS-NEO is an antigen delivery product developed by Advaxis to identify neoantigens is under Phase 1 of clinical trials. Furthermore, Genocea Biosciences, Inc. is evaluating a personalized adjuvant vaccine, GEN-009 Neoantigen Vaccine, for the treatment of patients with solid tumors. Currently, the candidate is in a Phase 1/2a clinical trial. With the assumption of the probable commercial availability of neoantigen for clinical treatment in 2023. Analyzing this, the market has been forecasted from 2023 to 2028. Browse Complete Report @ https://www.theinsightpartners.com/reports/neoantigens-market/ About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors etc. Contact Us: Call: +1-646-491-9876 Email: sales@theinsightpartners.com Like it? Share it! More by this author |